Group 1 - NuraNavX, a brain science AI company, recently completed a multi-million yuan angel round financing led by K2 Venture Partners, with funds aimed at market promotion and further R&D of AI brain connectomics products [1] - The company's AI-based individualized brain network mapping, which can be understood as a "GPS for the brain," reveals how different brain regions connect, crucial for understanding complex brain diseases [1] - NuraNavX divides each patient's brain into 379 unique regions based on MRI data and has identified over 20 important brain functional networks, enabling personalized brain network maps for surgical protection and targeted treatment of central nervous system diseases like depression and anxiety [1] Group 2 - The company has established self-operated neuroregulation clinics in Shenzhen and Shanghai, providing treatments for various conditions including depression, anxiety, insomnia, and schizophrenia [2] - In addition to medical-grade products and services, NuraNavX's AI brain connectomics software supports researchers in brain science and has developed consumer-level brain health assessment reports to identify potential risks early [2]

Core Viewpoint - NuraNavX, a brain science AI company, has recently completed a multi-million yuan angel round financing, primarily aimed at market promotion and further research of its AI brain connectomics products [1] Group 1: Company Overview - NuraNavX focuses on brain connectomics, analyzing the connections and networking of neurons to understand brain functions and mechanisms, which is crucial for understanding complex brain diseases [1][2] - The company has treated over 1,000 patients in domestic clinical settings using its AI-based individualized brain network mapping technology [1] Group 2: Technology and Applications - The company utilizes MRI data to divide each patient's brain into 379 unique regions and studies over 20 important brain functional networks through its proprietary SCA (Structural Connectome Atlas) technology [2] - SCA technology employs machine learning to extract structural features of neural fiber bundles, creating personalized brain network models for surgical planning and treatment of central nervous system diseases [2][3] Group 3: Surgical Applications - Nura Surgical software aids neurosurgeons in tumor removal by presenting the patient's brain network and surrounding fiber bundles, helping to evaluate the importance of these bundles and optimize surgical paths [3] - The software has received a Class II medical device registration in China and is already in use in multiple top-tier hospitals, with applications in over 10,000 neurosurgeries internationally [3] Group 4: Mental Health Treatment - The AI brain connectomics system shows potential in the neuro-regulation treatment of functional brain diseases, addressing clinical pain points in diagnosing and treating conditions like depression and anxiety [6][8] - The company is collaborating with hospitals to conduct larger-scale clinical trials for severe mental illnesses, while also establishing self-operated neuro-regulation clinics in major cities [9] Group 5: Market Potential - With over 1 billion people affected by neurological disorders globally, the increasing prevalence due to aging populations and lifestyle changes presents a significant market opportunity for innovative treatment solutions [9]